Breaking News

Scorpius Holdings Expands Operations in San Antonio

Opens new storage and testing facility in response to growing demand for biomanufacturing services.

Scorpius Holdings Inc., an integrated contract development and manufacturing organization (CDMO), is expanding its operational footprint in San Antonio, Texas, with the opening of its new storage and testing facility.
 
This expansion increases Scorpius’ warehouse facilities more than sevenfold, from ~3,000 square feet to ~22,000 square feet. It comes in response to the growing demand for Scorpius’ biomanufacturing services and the need to accommodate its expanding client base.
 
The new facility is designed to meet or exceed industry standards with appropriate storage, continuity, and security controls for biopharmaceutical materials. It will feature specialized storage areas with temperatures maintained between -20°C and -80°C for raw materials, alongside spaces designated for contained sampling and quality control testing. Additionally, it will accommodate bulk drug substance storage, ensuring clients’ products are stored under optimal conditions throughout the development and production cycles.
 
Notably, the facility will include a robust stability program, which will bolster Scorpius’ service offerings by providing in-house stability storage capabilities to foster a smooth transition into onsite testing. Not only does this add a new dimension to the Company’s capabilities, but it also introduces an additional revenue stream, further solidifying Scorpius’ position in the market.
 
Jeff Wolf, CEO of Scorpius Holdings, commented, “These new capabilities enable us to offer our clients continuity through their supply chain and meet their needs from process development through drug substance release. This strategic expansion reflects our commitment to excellence and our dedication to supporting our clients’ overall needs.”

More Scorpius News

Earlier this month, Scorpius Holdings announced the successful validation of its microbial facilities—signifying that Scorpius’ microbial cleanrooms are now officially approved to manufacture current Good Manufacturing Practice (cGMP) microbial biologic drugs.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters